Close Menu

Northwestern University's Richard Silverman and his work leading to the discovery and marketing of Pfizer's blockbuster, Lyrica, are profiled in this Chicago Tribune article. According to Silverman, who took one-fourth of the $700 million in royalties Northwestern made selling a portion of its rights to New York-based Royalty Pharma, finding a billion-dollar drug takes as much scientific curiosity as luck.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.